"Founded in 1981, Dermatology Associates of Plymouth Meeting is one of the areas largest, most progressive dermatology group practices. We specialize in diagnosis, treatment and counseling for diseases of the skin, hair and nails. We are also a leader in cosmetic dermatology and clinical aesthetics offering a multitude of skin, body and laser services that can enhance your appearance, improved self image and sense of well being. We are also proud to have a board certified Mohs surgeon on staff."

During the past decade, Dermatology Associates of Plymouth Meeting conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology Associates of Plymouth Meeting" #1 sponsor was "Concert Pharmaceuticals" with 3 trials, followed by "Incyte Corporation" with 3 trials sponsored, "Alma Lasers" with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "Cynosure, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Associates of Plymouth Meeting" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology Associates of Plymouth Meeting" are "Alopecia Areata" (4 trials), "Psoriasis" (3 trials), "Body Fat" (1 trials), "Cutaneous Common Warts" (1 trials) and "Hidradenitis Suppurativa" (1 trials). Many other conditions were trialed in "Dermatology Associates of Plymouth Meeting" in a lesser frequency.

Most popular intervention types in "Dermatology Associates of Plymouth Meeting" are "Drug" (9 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "CTP-543" (2 trials), "Placebo" (2 trials), "Ruxolitinib cream" (2 trials), "Vehicle" (2 trials) and "Alefacept exposure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology Associates of Plymouth Meeting" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Dermatology Associates of Plymouth Meeting". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Dermatology Associates of Plymouth Meeting, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology Associates of Plymouth Meeting, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".